BMS202 : Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2

GW2580 : Bacterial nanocellulose as a simple and tailorable platform for controlled drug release

LY2228820 : RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy